Scandonest L (Novocol Pharmaceutical of Canada, Inc)
Welcome to the PulseAid listing for the Scandonest L drug offered from Novocol Pharmaceutical of Canada, Inc. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novocol Pharmaceutical of Canada, Inc |
NON-PROPRIETARY NAME: | Mepivacaine Hydrochloride and Levonordefrin |
SUBSTANCE NAME: | MEPIVACAINE HYDROCHLORIDE; LEVONORDEFRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-06-27 |
END MARKETING DATE: | 0000-00-00 |
Scandonest L HUMAN PRESCRIPTION DRUG Details:
Item Description | Scandonest L from Novocol Pharmaceutical of Canada, Inc |
LABELER NAME: | Novocol Pharmaceutical of Canada, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; .05(mg/mL; mg/mL) |
START MARKETING DATE: | 2013-06-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51004-1097_59fcd689-a6a3-4739-a982-6b41c249de7b |
PRODUCT NDC: | 51004-1097 |
APPLICATION NUMBER: | ANDA088388 |
Other MEPIVACAINE HYDROCHLORIDE; LEVONORDEFRIN Pharmaceutical Manufacturers / Labelers: